Unknown

Dataset Information

Clinical significance of circulating tumor cells and metabolic signatures in lung cancer after surgical removal.


ABSTRACT:

Background

Lung cancer (LC) remains the deadliest form of cancer globally. While surgery remains the optimal treatment strategy for individuals with early-stage LC, what the metabolic consequences are of such surgical intervention remains uncertain.

Methods

Negative enrichment-fluorescence in situ hybridization (NE-FISH) was used in an effort to detect circulating tumor cells (CTCs) in pre- and post-surgery peripheral blood samples from 51 LC patients. In addition, targeted metabolomics analyses, multivariate statistical analyses, and pathway analyses were used to explore surgery-associated metabolic changes.

Results

LC patients had significantly higher CTC counts relative to healthy controls with 66.67% of LC patients having at least 1 detected CTC before surgery. CT

SUBMITTER: Yang D 

PROVIDER: S-EPMC7301449 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature